| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Comparison of Patients’ Prescribed, Self-Reported, and Actual Intake of Supplemental EPA/DHA
|
Backes, James
|
|
2016
|
10 |
3 |
p. 699-700
2 p.
|
artikel
|
| 2 |
Active Familial Hypercholesterolemia Case-Finding Through MEDPED General Population Criteria*
|
Andersen, Lars
|
|
2016
|
10 |
3 |
p. 672-674
3 p.
|
artikel
|
| 3 |
Acute Hyperthyroidism Lowers LDL-C Discordantly More than LDL-P*
|
Agrawal, Nidhi
|
|
2016
|
10 |
3 |
p. 690-691
2 p.
|
artikel
|
| 4 |
Acute Leriche Syndrome In A Young Female: First Manifestation Of Atherosclerosis
|
Barvalia, Mihir
|
|
2016
|
10 |
3 |
p. 706-707
2 p.
|
artikel
|
| 5 |
Acute Pancreatitis is Highly Prevalent and Complications can be Fatal in Patients with Familial Chylomicronemia: Results From a Survey of Lipidologist
|
Gaudet, Daniel
|
|
2016
|
10 |
3 |
p. 680-681
2 p.
|
artikel
|
| 6 |
Advanced Lipid Testing: Markers For Atherosclerotic Disease
|
Saini, Nidhi
|
|
2016
|
10 |
3 |
p. 660-661
2 p.
|
artikel
|
| 7 |
Advanced Lipid Testing Uncovers Hidden Cardiovascular Disease Risk: A Case Control Analysis
|
Stock, Eveline
|
|
2016
|
10 |
3 |
p. 660-
1 p.
|
artikel
|
| 8 |
Advanced Therapies In The Management Of Homozygous Familial Hypercholesterolemia*
|
Weiss, Matthew C.
|
|
2016
|
10 |
3 |
p. 688-689
2 p.
|
artikel
|
| 9 |
Alirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis: Rationale and design of the ODYSSEY ESCAPE trial
|
Moriarty, Patrick M.
|
|
2016
|
10 |
3 |
p. 627-634
8 p.
|
artikel
|
| 10 |
Alirocumab Versus Ezetimibe Over 104 Weeks In Individuals With Hypercholesterolemia And High Cardiovascular Risk: Final Results From ODYSSEY COMBO II
|
El Shahawy, Mahfouz
|
|
2016
|
10 |
3 |
p. 717-718
2 p.
|
artikel
|
| 11 |
An Evaluation Of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors In Patients With Diabetes Mellitus*
|
Stryker, Matthew
|
|
2016
|
10 |
3 |
p. 720-
1 p.
|
artikel
|
| 12 |
Antisense Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes
|
Digenio, Andres
|
|
2016
|
10 |
3 |
p. 707-708
2 p.
|
artikel
|
| 13 |
A Phase 3 Randomized Trial Evaluating Alirocumab 300 mg Every 4 Weeks (Q4W) as Monotherapy or Add-On to Statin: ODYSSEY CHOICE I
|
Roth, Eli M.
|
|
2016
|
10 |
3 |
p. 716-717
2 p.
|
artikel
|
| 14 |
A Placebo-Controlled Trial of a Proprietary Lipid-Lowering Nutraceutical Supplement in the Management of Dyslipidemia
|
Zhang, Bodi
|
|
2016
|
10 |
3 |
p. 699-
1 p.
|
artikel
|
| 15 |
Are Changes In 25(OH) Vitamin D Levels And Changes In Insulin Secretion Mediated By Changes In Visceral Adiposity? Results From A Lifestyle Intervention Study In Viscerally Obese Men*
|
Gangloff, Anne
|
|
2016
|
10 |
3 |
p. 723-724
2 p.
|
artikel
|
| 16 |
Are There Differences In The Perceived Health-Related Quality Of Life Between Children At Risk For Premature Cardiovascular Disease and Parents?
|
Vinson, Amelia
|
|
2016
|
10 |
3 |
p. 704-705
2 p.
|
artikel
|
| 17 |
A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality
|
Wadhera, Rishi K.
|
|
2016
|
10 |
3 |
p. 472-489
18 p.
|
artikel
|
| 18 |
Asparaginase-associated concurrence of hyperlipidemia, hyperglobulinemia, and thrombocytosis was successfully treated by centrifuge/membrane hybrid double-filtration plasmapheresis
|
Wang, Taina
|
|
2016
|
10 |
3 |
p. 646-649
4 p.
|
artikel
|
| 19 |
Assessment Of Lipid Profile In Hypertensive And Non-Hypertensive Males: A Case Control Study
|
Senarathne, Ravithima
|
|
2016
|
10 |
3 |
p. 704-
1 p.
|
artikel
|
| 20 |
Association Between Frequent Gene-Smoking Interactions And Plama Apolipoprotein B Levels Among Low-Risk Individuals
|
Roy, Nathalie
|
|
2016
|
10 |
3 |
p. 671-672
2 p.
|
artikel
|
| 21 |
Atherosclerotic Arteries with Cholesterol Crystals Enhance Bacterial Growth: Risk for Plaque Destabilization*
|
Baig, Imran
|
|
2016
|
10 |
3 |
p. 710-
1 p.
|
artikel
|
| 22 |
Attainment of ACC/AHA Recommended LDL-C Lowering With Statin and Ezetimibe+Statin Therapies†
|
Toth, Peter
|
|
2016
|
10 |
3 |
p. 683-684
2 p.
|
artikel
|
| 23 |
Baseline Undertreatment of Adults with Newly Diagnosed Familial Hypercholesterolemia by Genomic Sequencing*
|
Jones, Laney
|
|
2016
|
10 |
3 |
p. 692-693
2 p.
|
artikel
|
| 24 |
CAT-2003, an Analog of CAT-2054 and a Novel Oral SREBP Inhibitor, Inhibits Inflammation and Fibrosis in a Murine Model of Nonalcoholic Steatohepatitis
|
Picarella, Dominic
|
|
2016
|
10 |
3 |
p. 722-723
2 p.
|
artikel
|
| 25 |
Changes in carotid plaque tissue composition in subjects who continued and discontinued statin therapy
|
Du, Ruixue
|
|
2016
|
10 |
3 |
p. 587-593
7 p.
|
artikel
|
| 26 |
Changes In 25(OH) Vitamin D Levels, Leptin Levels And Visceral Adipose Tissue Volume: Results From A Lifestyle Intervention Study In Viscerally Obese*
|
Gangloff, Anne
|
|
2016
|
10 |
3 |
p. 723-
1 p.
|
artikel
|
| 27 |
Characterization of the unique Chinese W483X mutation in the low-density lipoprotein–receptor gene in young patients with homozygous familial hypercholesterolemia
|
Jiang, Long
|
|
2016
|
10 |
3 |
p. 538-546.e5
5.4599463E7 p.
|
artikel
|
| 28 |
Clinical Characteristics And LDL-C Achievement Rates In 506 FH Patients From 4 Russian Lipid Clinics
|
Susekov, Andrey
|
|
2016
|
10 |
3 |
p. 698-
1 p.
|
artikel
|
| 29 |
Combined Cascade Screening And Patient Education For Familial Hypercholesterolemia: Genetic Results From A Family Shared Medical Appointment Pilot Study
|
Davis, Tina
|
|
2016
|
10 |
3 |
p. 674-676
3 p.
|
artikel
|
| 30 |
Comparison of different statin therapy to change low-density lipoprotein cholesterol and high-density lipoprotein cholesterol level in Korean patients with and without diabetes
|
Khang, Ah Reum
|
|
2016
|
10 |
3 |
p. 528-537.e3
536473 p.
|
artikel
|
| 31 |
Consensus between the American College of Cardiology and the National Lipid Association on the use of non-statin therapy for atherosclerotic cardiovascular disease prevention
|
Orringer, Carl E.
|
|
2016
|
10 |
3 |
p. 458-461
4 p.
|
artikel
|
| 32 |
Correlation of Weight and LDL Level Changes with Age in Males vs. Females
|
Kolakalapudi, Pavani
|
|
2016
|
10 |
3 |
p. 689-690
2 p.
|
artikel
|
| 33 |
Cost Per Effectively Treated Patient With Evolocumab 140mg, Alirocumab 75/150mg Among Patients Using PCSK9 Inhibitor Therapy
|
Gitlin, Matthew
|
|
2016
|
10 |
3 |
p. 685-686
2 p.
|
artikel
|
| 34 |
Description Of Discordance Between LDL Cholesterol, Non-HDL Cholesterol, And LDL Particle Number Among Patients Of A Lipid Clinic
|
Gaborcik, Joshua
|
|
2016
|
10 |
3 |
p. 658-
1 p.
|
artikel
|
| 35 |
Detecting Severe Hyperlipidemia In the General Population Through Occupational Screening*
|
Andersen, Lars
|
|
2016
|
10 |
3 |
p. 667-668
2 p.
|
artikel
|
| 36 |
Development And Implementation Of A Clinical Lipidology Subspecialty Program For Healthcare Professionals
|
Elkins, Casey
|
|
2016
|
10 |
3 |
p. 703-704
2 p.
|
artikel
|
| 37 |
Dietary Oxidized Linoleic Acid Ameliorate Plasma ApoA5 levels in C57BL mice
|
Garelnabi, Mahdi
|
|
2016
|
10 |
3 |
p. 705-
1 p.
|
artikel
|
| 38 |
Disparity in Lipid Control between Cardiology Attending and Cardiology Fellow Clinics
|
Carney, Clare
|
|
2016
|
10 |
3 |
p. 682-683
2 p.
|
artikel
|
| 39 |
Does Body Mass Index Correlate To Lipoproteins And Triglycerides? Findings From DYSIS In 52.916 Statin Treated Patients
|
Lautsch, Dominik
|
|
2016
|
10 |
3 |
p. 674-
1 p.
|
artikel
|
| 40 |
Does Body Mass Index Impact The Choice Of Lipid Lowering Treatment?
|
Lautsch, Dominik
|
|
2016
|
10 |
3 |
p. 694-697
4 p.
|
artikel
|
| 41 |
Does Statin Dose Titration Lead to LDL-C Goal Achievement among Patients with Clinical ASCVD or FH: An Observational Study Using Real World Data
|
Bonafede, Machoan
|
|
2016
|
10 |
3 |
p. 686-687
2 p.
|
artikel
|
| 42 |
Do The Lipid Profiles Of Type 2 Diabetes Mellitus Patients And Controls Differ Based On Their Body Fat Percentage And Visceral Fat Levels?*
|
Rathnayake, Gayathri
|
|
2016
|
10 |
3 |
p. 663-664
2 p.
|
artikel
|
| 43 |
Early Experience With Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors In Patients Treated In An Outpatient Lipid Clinic
|
Hirsch, Andrea
|
|
2016
|
10 |
3 |
p. 716-
1 p.
|
artikel
|
| 44 |
Editorial Board
|
|
|
2016
|
10 |
3 |
p. A1-A2
nvt p.
|
artikel
|
| 45 |
Editorial commentary: Dietary management of familial chylomicronemia syndrome
|
Williams, Lauren
|
|
2016
|
10 |
3 |
p. 462-465
4 p.
|
artikel
|
| 46 |
Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein(a)
|
Yeang, Calvin
|
|
2016
|
10 |
3 |
p. 594-603
10 p.
|
artikel
|
| 47 |
Effects of Eicosapentaenoic Acid Plus Docosapentaenoic Acid and Eicosapentaenoic Acid Alone on Fasting and Postprandial Lipids
|
Maki, Kevin C.
|
|
2016
|
10 |
3 |
p. 700-
1 p.
|
artikel
|
| 48 |
Efficacy and Safety of Gemcabene as Add-on to Stable Statin Therapy in Patients with Hypercholesterolemia
|
Koren, Michael
|
|
2016
|
10 |
3 |
p. 719-
1 p.
|
artikel
|
| 49 |
Eicosapentaenoic Acid Reduces Hyperglycemia-induced Small Dense Low-Density Lipoprotein Oxidation In Vitro Differently From Docosahexaenoic Acid
|
Sherratt, Samuel
|
|
2016
|
10 |
3 |
p. 701-
1 p.
|
artikel
|
| 50 |
Environmental and Biological Markers of Survival in Septuagenarians and Octogenarians Carrying FH-Causing LDLR Gene Mutations*
|
Khoury, Etienne
|
|
2016
|
10 |
3 |
p. 671-
1 p.
|
artikel
|
| 51 |
Epicardial adipose tissue—Truly at the heart of the coronaries?
|
Phan, Binh An P.
|
|
2016
|
10 |
3 |
p. 469-471
3 p.
|
artikel
|
| 52 |
Evacetrapib alone or in combination with statins lowers lipoprotein(a) and total and small LDL particle concentrations in mildly hypercholesterolemic patients
|
Nicholls, Stephen J.
|
|
2016
|
10 |
3 |
p. 519-527.e4
5.269482E6 p.
|
artikel
|
| 53 |
Evaluating The Roles Of PCSK9 And Specific Receptors In Lipoprotein(A) Catabolism
|
Koschinsky, Marlys
|
|
2016
|
10 |
3 |
p. 720-721
2 p.
|
artikel
|
| 54 |
Evaluation of the Performance of Assure® Lance Plus 30G and 25G Safety Lancets
|
Walker, Julie
|
|
2016
|
10 |
3 |
p. 661-
1 p.
|
artikel
|
| 55 |
From the Editor: National Lipid Association, the annual scientific sessions, triglycerides, and apolipoprotein-CIII
|
Brown, William Virgil
|
|
2016
|
10 |
3 |
p. 445-446
2 p.
|
artikel
|
| 56 |
Gender and Race Related Variations in Weight and Cholesterol Control
|
Shofu, Abimbola
|
|
2016
|
10 |
3 |
p. 668-
1 p.
|
artikel
|
| 57 |
Gene Expression Signature of Recurrent Acute Pancreatitis Risk in LPL Deficiency and Severe Hypertriglyceridemia
|
Tremblay, Karine
|
|
2016
|
10 |
3 |
p. 681-
1 p.
|
artikel
|
| 58 |
Genetic and Functional investigation of LPL Independent Pathways of TG-Rich Lipoproteins Catabolism in Severe Hypertriglyceridemia and Chylomicronemia
|
Gaudet, Daniel
|
|
2016
|
10 |
3 |
p. 664-
1 p.
|
artikel
|
| 59 |
Genetic diagnosis of familial hypercholesterolemia in Han Chinese
|
Chiou, Kuan-Rau
|
|
2016
|
10 |
3 |
p. 490-496
7 p.
|
artikel
|
| 60 |
High-Density Lipoprotein: The Unimagined Biomarker For Human Health Assessment
|
Altmann, Scott
|
|
2016
|
10 |
3 |
p. 657-658
2 p.
|
artikel
|
| 61 |
Higher circulating GlycA, a pro-inflammatory glycoprotein biomarker, relates to lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in diabetic or metabolic syndrome subjects
|
Gruppen, Eke G.
|
|
2016
|
10 |
3 |
p. 512-518
7 p.
|
artikel
|
| 62 |
High Lipoprotein (a) In A Patient With Coronary Artery Disease And Venous Thromboembolism
|
Barvalia, Mihir
|
|
2016
|
10 |
3 |
p. 655-
1 p.
|
artikel
|
| 63 |
Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C-III levels in patients from the MARINE and ANCHOR studies
|
Ballantyne, Christie M.
|
|
2016
|
10 |
3 |
p. 635-645.e1
5816 p.
|
artikel
|
| 64 |
Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) in Women With Very High Triglyceride Levels: Results From the MARINE Study
|
Mosca, Lori
|
|
2016
|
10 |
3 |
p. 701-702
2 p.
|
artikel
|
| 65 |
Impact Of Recent Cholesterol And Hypertension Guidelines On Lipid And BP Control
|
Gadde, Sushee
|
|
2016
|
10 |
3 |
p. 683-
1 p.
|
artikel
|
| 66 |
Improvement in Atherogenic Dyslipidemia at 70 Days Following a Reduced Carbohydrate Intervention for Treatment of Type 2 Diabetes
|
Hallberg, Sarah
|
|
2016
|
10 |
3 |
p. 665-
1 p.
|
artikel
|
| 67 |
Improvements in Carotid Artery Intima-Media Thickness With Icosapent Ethyl in Three Patients With Non-HDL-C ≥130 mg/dL: A Case Series
|
Reddy, Kota
|
|
2016
|
10 |
3 |
p. 702-703
2 p.
|
artikel
|
| 68 |
Instruction for Authors
|
|
|
2016
|
10 |
3 |
p. A9-A10
nvt p.
|
artikel
|
| 69 |
Inverse Relationship Between Major Adverse Cardiovascular Events and non-High-Density Lipoprotein Cholesterol and Apolipoprotein B in Phase 3 Trials of Alirocumab
|
Davidson, Michael H.
|
|
2016
|
10 |
3 |
p. 724-
1 p.
|
artikel
|
| 70 |
JCL roundtable: Lessons from genetic variants altering lipoprotein metabolism
|
Brown, William Virgil
|
|
2016
|
10 |
3 |
p. 448-457
10 p.
|
artikel
|
| 71 |
Lifetime Cardiovascular Risk Reduction With Intensive Lipid Therapy: 25-Year Follow-Up Of The Familial Atherosclerosis Treatment Study – Observational
|
Zhao, Xue-Qiao
|
|
2016
|
10 |
3 |
p. 687-
1 p.
|
artikel
|
| 72 |
Lipid Changes 8 Years Post Gastric Bypass In Adolescents With Severe Obesity* †
|
Shah, Amy
|
|
2016
|
10 |
3 |
p. 705-706
2 p.
|
artikel
|
| 73 |
Lipid Management in Clinical Practice: Optimizing Outcomes Through Dual Physician-Patient Education
|
Spyropoulos, Jelena
|
|
2016
|
10 |
3 |
p. 684-685
2 p.
|
artikel
|
| 74 |
Lipoprotein(a) As A Clinical Decision-Aid Tool*
|
Weiss, Matthew
|
|
2016
|
10 |
3 |
p. 659-
1 p.
|
artikel
|
| 75 |
Lipoprotein-associated phospholipase A2 distribution among lipoproteins differs in type 1 diabetes
|
Jarvie, Jennifer L.
|
|
2016
|
10 |
3 |
p. 577-586
10 p.
|
artikel
|
| 76 |
Lipoprotein-Derived Insulin Resistance (LP=IR) Score Vs. Standard Measures Of Insulin Resistance In Youth
|
Hamilton, Luke
|
|
2016
|
10 |
3 |
p. 666-667
2 p.
|
artikel
|
| 77 |
Lipoprotein Measurement in Patients Infected with HIV: Is Cholesterol Content of HDL and LDL Discordant with Particle Number?
|
Myerson, Merle
|
|
2016
|
10 |
3 |
p. 693-
1 p.
|
artikel
|
| 78 |
Lomitapide Observational Worldwide Evaluation Registry (LOWER): One-Year Data†
|
Underberg, James
|
|
2016
|
10 |
3 |
p. 690-
1 p.
|
artikel
|
| 79 |
Long-Term Efficacy and Safety of Lomitapide for the Treatment of Homozygous Familial Hypercholesterolemia: Results of the Phase 3 Extension Trial †
|
Blom, Dirk
|
|
2016
|
10 |
3 |
p. 708-710
3 p.
|
artikel
|
| 80 |
Loss of Function Variant PCSK9 R46L is Associated with a Reduced Prevalence of Recurrent Cardiovascular Events in Familial Hypercholesterolemia†
|
Paquette, Martine
|
|
2016
|
10 |
3 |
p. 670-671
2 p.
|
artikel
|
| 81 |
Low-Density Lipoprotein Cholesterol Goal Attainment: Time-Sensitivity Analysis Using National Health And Nutrition Examination Survey Data (2003–2012) †
|
Toth, Peter P.
|
|
2016
|
10 |
3 |
p. 662-663
2 p.
|
artikel
|
| 82 |
Metabolic Syndrome And Low-Density Lipoprotein Cholesterol Goal Attainment In The National Health And Nutrition Examination Survey (2003–2012) †
|
Toth, Peter
|
|
2016
|
10 |
3 |
p. 721-722
2 p.
|
artikel
|
| 83 |
Neo HDL Produced by the Streptococcal Serum Opacity Factor Activity against Human High Density Lipoproteins is Hepatically Removed via Dual Mechanisms
|
Rodriguez, Perla
|
|
2016
|
10 |
3 |
p. 679-680
2 p.
|
artikel
|
| 84 |
News from the NLA
|
|
|
2016
|
10 |
3 |
p. 447-
1 p.
|
artikel
|
| 85 |
No Changes In Average Lipid Profiles In The United States From 2003 To 2012: The National Health And Nutrition Examination Survey 2003–2012†
|
Toth, Peter P.
|
|
2016
|
10 |
3 |
p. 661-662
2 p.
|
artikel
|
| 86 |
Novel APOB missense variants, A224T and V925L, in a black South African woman with marked hypocholesterolemia
|
Miller, Sharon A.
|
|
2016
|
10 |
3 |
p. 604-609
6 p.
|
artikel
|
| 87 |
Omega-3 Carboxylic Acids In Severe Hypertriglyceridemia With Triglycerides Greater Than 885mg/Dl (>10mmol/L)
|
De Bruin, Tjerk
|
|
2016
|
10 |
3 |
p. 702-
1 p.
|
artikel
|
| 88 |
Overlap Of Diabetes And Atherogenic Dyslipidemia In The Adult US Population, 2011–2012*
|
Qin, Li
|
|
2016
|
10 |
3 |
p. 710-714
5 p.
|
artikel
|
| 89 |
PCSK9 Inhibitor Non-Response In A Patient With Preserved LDL Receptor Function: A Case Study*
|
Losh, Chiara
|
|
2016
|
10 |
3 |
p. 719-720
2 p.
|
artikel
|
| 90 |
Pediatric Cholesterol Screening In Italy: The Spif Project†
|
Buonuomo, Paola Sabrina
|
|
2016
|
10 |
3 |
p. 685-
1 p.
|
artikel
|
| 91 |
Performance of the GLUCOCARD® Shine by Health Care Professionals Against the ISO 15197:2013 Accuracy Criteria
|
Walker, Julie
|
|
2016
|
10 |
3 |
p. 664-665
2 p.
|
artikel
|
| 92 |
Phase 1 Multiple Ascending Dose Study of CAT-2054, a Novel Oral Sterol Regulatory Element Binding Protein Inhibitor
|
Donovan, Joanne
|
|
2016
|
10 |
3 |
p. 715-716
2 p.
|
artikel
|
| 93 |
Plasma Ceramides Independently Predict Coronary Artery Disease and Major Adverse Cardiovascular Events*
|
Meeusen, Jeffrey
|
|
2016
|
10 |
3 |
p. 656-657
2 p.
|
artikel
|
| 94 |
Prevalence and Linkage of Cerebrotendinous Xanthomatosis and Phytosterolemia in the Boston Heart Diagnostics Data Base
|
Schaefer, Ernst
|
|
2016
|
10 |
3 |
p. 677-678
2 p.
|
artikel
|
| 95 |
Prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in Brazil: Baseline of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)
|
Lotufo, Paulo A.
|
|
2016
|
10 |
3 |
p. 568-576
9 p.
|
artikel
|
| 96 |
Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia
|
Ohta, Naotaka
|
|
2016
|
10 |
3 |
p. 547-555.e5
5.5499454E7 p.
|
artikel
|
| 97 |
Provider understanding of the 2013 ACC/AHA cholesterol guideline
|
Virani, Salim S.
|
|
2016
|
10 |
3 |
p. 497-504.e4
5.039504E6 p.
|
artikel
|
| 98 |
Race-Related Variations in Lipid Parameters in a Cardiology Clinic
|
Moses, Andrew
|
|
2016
|
10 |
3 |
p. 689-
1 p.
|
artikel
|
| 99 |
Rare and common variants in LPL and APOA5 in Thai subjects with severe hypertriglyceridemia: A resequencing approach
|
Khovidhunkit, Weerapan
|
|
2016
|
10 |
3 |
p. 505-511.e1
4606 p.
|
artikel
|
| 100 |
Real-World Changes in LDL-C among High-Risk Patients Switching from Atorvastatin to Rosuvastatin
|
Lewis, Sandra
|
|
2016
|
10 |
3 |
p. 691-692
2 p.
|
artikel
|
| 101 |
Regression Of Atheroma On Serial CIMT While On 60% Fat Diet
|
Edwards, Brian
|
|
2016
|
10 |
3 |
p. 655-656
2 p.
|
artikel
|
| 102 |
Relationship Between Coronary Atherosclerotic Plaque Burden Measured By Intravascular Ultrasound And Cardiovascular Disease Outcomes
|
Quek, Ruben
|
|
2016
|
10 |
3 |
p. 681-682
2 p.
|
artikel
|
| 103 |
Relationship of epicardial fat thickness and nonalcoholic fatty liver disease to coronary artery calcification: From the CAESAR study
|
Kim, Byung Jin
|
|
2016
|
10 |
3 |
p. 619-626.e1
5642 p.
|
artikel
|
| 104 |
Safety and efficacy of evinacumab, a monoclonal antibody to ANGPTL3, in patients with homozygous familial hypercholesterolemia receiving concomitant lipid-lowering therapies
|
Gaudet, Daniel
|
|
2016
|
10 |
3 |
p. 715-
1 p.
|
artikel
|
| 105 |
Sebelipase Alfa Improves Atherogenic Measures In Adults And Children With Lysosomal Acid Lipase Deficiency
|
Wilson, Don
|
|
2016
|
10 |
3 |
p. 678-679
2 p.
|
artikel
|
| 106 |
Severe hypercholesterolemia and liver disease in a 3-year old
|
Patel, Amol M.
|
|
2016
|
10 |
3 |
p. 650-653
4 p.
|
artikel
|
| 107 |
Standard Lipid Testing vs. Direct Measures of Atherogenic Lipoproteins†
|
Diffenderfer, Margaret
|
|
2016
|
10 |
3 |
p. 658-659
2 p.
|
artikel
|
| 108 |
Statins Wrongly Accused Of Causing Myalgia – Guilty by Association
|
Ruisinger, Janelle
|
|
2016
|
10 |
3 |
p. 698-699
2 p.
|
artikel
|
| 109 |
Statin Use In Adults With Diabetes Before And After Guideline Revisions From Leading Medical Associations*
|
Mitri, Joanna
|
|
2016
|
10 |
3 |
p. 663-
1 p.
|
artikel
|
| 110 |
Statin Use In Adults With Diabetes By Primary Care Physicians Versus Endocrinologists*
|
Mitri, Joanna
|
|
2016
|
10 |
3 |
p. 687-688
2 p.
|
artikel
|
| 111 |
Superiority of lipoprotein particle number to detect associations with arterial thickness and stiffness in obese youth with and without prediabetes
|
Shah, Amy S.
|
|
2016
|
10 |
3 |
p. 610-618
9 p.
|
artikel
|
| 112 |
Table of Contents
|
|
|
2016
|
10 |
3 |
p. A5-A7
nvt p.
|
artikel
|
| 113 |
The Association Of Nut Consumption With Cardiovascular Mortality And Coronary Heart Disease Risk In Women*
|
Imran, Tasnim
|
|
2016
|
10 |
3 |
p. 669-670
2 p.
|
artikel
|
| 114 |
The Linkage of Tangier Disease with Premature Coronary Artery Disease: Relationship with Low Density Lipoproteins and Hypersplenism
|
Schaefer, Ernst
|
|
2016
|
10 |
3 |
p. 677-
1 p.
|
artikel
|
| 115 |
The Natural History of Lecithin Cholesteryl Acyltransferase (LCAT) Deficiency
|
Shamburek, Robert
|
|
2016
|
10 |
3 |
p. 693-694
2 p.
|
artikel
|
| 116 |
The Spectrum of Lysosomal Acid Lipase Activity in a Lipid Clinic Population
|
Friedrich, Debra
|
|
2016
|
10 |
3 |
p. 654-655
2 p.
|
artikel
|
| 117 |
The very high residual degree of death and disease from atherosclerosis needs new approaches
|
Makover, Michael E.
|
|
2016
|
10 |
3 |
p. 466-468
3 p.
|
artikel
|
| 118 |
Treatment Of A Patient Homozygous For Familial Defective Apolipoprotein B-100 With Evolocumab: A Case Study
|
Andersen, Rolf
|
|
2016
|
10 |
3 |
p. 676-677
2 p.
|
artikel
|
| 119 |
Treatment patterns and LDL-C goal attainment in patients with diabetes: Temporal trends analysis from National Health and Nutrition Examination Survey†
|
Toth, Peter
|
|
2016
|
10 |
3 |
p. 708-
1 p.
|
artikel
|
| 120 |
Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intolerance
|
Thompson, Paul D.
|
|
2016
|
10 |
3 |
p. 556-567
12 p.
|
artikel
|
| 121 |
Unique Discordance of LDL-C Levels and Apo A1/Remnant Ratios in South Asians: Implications for Risk Stratification for Prevalent Diabetes Mellitus
|
Nelson, John
|
|
2016
|
10 |
3 |
p. 665-666
2 p.
|
artikel
|
| 122 |
Virtual Clinician Need Support, Health-Behavior Change, and Its Maintenance
|
Block, Robert
|
|
2016
|
10 |
3 |
p. 667-
1 p.
|
artikel
|
| 123 |
Weight and BMI Correlation According to Race and Gender
|
Haq, Ehtesham Ul
|
|
2016
|
10 |
3 |
p. 721-
1 p.
|
artikel
|
Tijdschrift beschrijving